AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 90 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,516,387 | $33,558,000 | 3.27% |
| Cormorant Asset Management, LP | 400,000 | $8,852,000 | 1.82% |
| RA Capital Management | 597,363 | $13,220,000 | 1.56% |
| HealthCor Management, L.P. | 900,000 | $19,917,000 | 1.02% |
| Eventide Asset Management | 166,200 | $3,678,000 | 0.51% |
| SPHERA FUNDS MANAGEMENT LTD. | 89,817 | $1,988,000 | 0.25% |
| STIFEL FINANCIAL CORP | 444,904 | $12,362,000 | 0.11% |
| EAGLE ASSET MANAGEMENT INC | 878,042 | $19,430,000 | 0.06% |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 110,000 | $2,434,000 | 0.05% |
| TFS CAPITAL LLC | 21,683 | $480,000 | 0.04% |